Patents by Inventor Gary Mitchell

Gary Mitchell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating diarrhea in a canine
    Patent number: 8900569
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria globosum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria globosum of the present invention are also provided.
    Type: Grant
    Filed: April 18, 2008
    Date of Patent: December 2, 2014
    Assignees: The Iams Company, Alimentary Health
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Mimicking the Metabolic Effect of Caloric Restrictions by Administration of Glucose Anti-Metabolites to Enhance Positive Response in a Mammal
    Publication number: 20140348975
    Abstract: The present invention relates to a use of composition comprising a glucose anti-metabolite and/or source of glucose anti-metabolite in a method of enhancing a positive affect and/or energetic arousal in a mammal.
    Type: Application
    Filed: May 21, 2014
    Publication date: November 27, 2014
    Applicant: The Iams Company
    Inventors: Gary Mitchell Davenport, Anna Katharine Shoveller, Margaret Ann Gooding, Donald Keith Ingram
  • Canine probiotic
    Patent number: 8894991
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the genus Lactobacilli obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Lactobacilli of the present invention are also provided.
    Type: Grant
    Filed: December 15, 2004
    Date of Patent: November 25, 2014
    Assignee: The Iams Company
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Methods of use of probiotic bifidobacteria for companion animals
    Patent number: 8877178
    Abstract: According to the present invention there are provided methods of use in companion animals of probiotic bacteria of the genus Bifidobacteria.
    Type: Grant
    Filed: December 15, 2004
    Date of Patent: November 4, 2014
    Assignees: The Iams Company, Alimentary Health Ltd.
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • System and Methods for Dynamic Network Address Modification
    Publication number: 20140317312
    Abstract: The invention presented herein permits split-routing to occur without any changes, modifications, or configuration of the requesting host, network stacks, network architectures and routing and forwarding behavior. The invention is carried out by way of a Module that intercepts the normal and standard DHCP communication between a requesting device and a DHCP server, and substitutes the elements within the server response with the Module's own predefined elements. These substitute elements leverage the behavior of standard protocols to gain desired device network behavior.
    Type: Application
    Filed: February 20, 2014
    Publication date: October 23, 2014
    Inventors: Gary Mitchell, Scott Whittle, Kurt Quasebarth
  • METHODS FOR USING 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUNDS
    Publication number: 20140301978
    Abstract: Novel 1,2,4-oxadiazole benzoic acid compounds, methods of using and pharmaceutical compositions comprising an 1,2,4-oxadiazole benzoic acid derivative are disclosed. The methods include methods of treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay, or ameliorating one or more symptoms associated therewith.
    Type: Application
    Filed: June 18, 2014
    Publication date: October 9, 2014
    Applicant: PTC Therapeutics Inc.
    Inventors: Gary Mitchell Karp, Seongwoo Hwang, Guangming Chen, Neil Gregory Almstead, Young-Choon Moon
  • Canine probiotic bifidobacteria globosum
    Patent number: 8840880
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria globosum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria globosum of the present invention are also provided.
    Type: Grant
    Filed: November 3, 2008
    Date of Patent: September 23, 2014
    Assignees: The Iams Company, Alimentary Health, Ltd.
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • METHODS OF TREATING OR PREVENTING OVERWEIGHT AND OBSESITY IN MAMMALS BY ADMINISTERING A COMPOSITION COMPRISING MANNOHEPTULOSE
    Publication number: 20140274920
    Abstract: The present invention is based on the discovery that mannoheptulose (mHep) reduces or inhibits the differentiation process of fat stem cells into adipocytes so as to decrease the body's fat storage capacity. Compositions comprising a mHep, process of making the compositions, and methods of using the compositions for treating or preventing overweight and obesity in a mammal, such as, for example, a growing pet (e.g., puppy, kitten), or a spayed/neutered pet, are encompassed by the present invention.
    Type: Application
    Filed: March 6, 2014
    Publication date: September 18, 2014
    Applicant: The Iams Company
    Inventor: Gary Mitchell Davenport
  • Canine probiotic
    Patent number: 8809035
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacterium globosum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacterium globosum of the present invention are also provided.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: August 19, 2014
    Assignees: The Iams Company, Alimentary Health, Ltd.
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Methods of use of probiotic for companion animals
    Patent number: 8802158
    Abstract: According to the present invention there are provided methods of use in companion animals of probiotic bacteria of the genus Lactobacilli.
    Type: Grant
    Filed: June 25, 2010
    Date of Patent: August 12, 2014
    Assignees: The Iams Company, Alimentary Health, Ltd.
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Methods for using 1,2,4-oxadiazole benzoic acid compounds
    Patent number: 8796322
    Abstract: Novel 1,2,4-oxadiazole benzoic acid compounds, methods of using and pharmaceutical compositions comprising an 1,2,4-oxadiazole benzoic acid derivative are disclosed. The methods include methods of treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay, or ameliorating one or more symptoms associated therewith.
    Type: Grant
    Filed: June 19, 2013
    Date of Patent: August 5, 2014
    Assignee: PTC Therapeutics, Inc.
    Inventors: Gary Mitchell Karp, Seongwoo Hwang, Guangming Chen, Neil Gregory Almstead, Young-Choon Moon
  • Putt break visualization instrument and method of use thereof
    Patent number: 8747244
    Abstract: A putt break visualization instrument useful for improving putting includes an elongated object such as a crossbar that extends from the shaft of a putter and is normal thereto. The golfer begins by addressing the golf ball. The golfer then holds the putter above the green by the handle in the manner of a plumb line so that the shaft of the putter is vertically oriented and the crossbar is horizontally oriented. The golfer then aligns the shaft with the uphill edge of the golf ball and moves the shaft up or down along the vertical so that the crossbar extends in proximity to the cup. The golfer may use a slider on the crossbar to mark the cup. The golfer may now evaluate how well he or she has addressed the golf ball, and either repeat the process if improvement is needed or make the putt.
    Type: Grant
    Filed: February 8, 2012
    Date of Patent: June 10, 2014
    Inventor: Gary Mitchell Bolen
  • Indole derivatives and methods for antiviral treatment
    Patent number: 8735414
    Abstract: The present invention is directed to compounds and forms and pharmaceutical compositions thereof useful for treating a viral infection, or for affecting viral activity by modulating viral replication.
    Type: Grant
    Filed: April 5, 2010
    Date of Patent: May 27, 2014
    Assignee: PTC Therapeutics, Inc.
    Inventors: Malcolm MacCoss, F. George Njoroge, Amin Nomeir, Guangming Chen, Song Xiao Huang, Ramesh Kakarla, Gary Mitchell Karp, William Joseph Lennox, Chunshi Li, Ronggang Liu, Yalei Liu, Christie Morrill, Steven D. Paget, Sean W Smith, James Takasugi, Anthony A. Turpoff, Hongyu Ren, Nanjing Zhang, Xiaoyan Zhang, Jin Zhu
  • METHODS FOR USING 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUNDS
    Publication number: 20130289007
    Abstract: Novel 1,2,4-oxadiazole benzoic acid compounds, methods of using and pharmaceutical compositions comprising an 1,2,4-oxadiazole benzoic acid derivative are disclosed. The methods include methods of treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay, or ameliorating one or more symptoms associated therewith.
    Type: Application
    Filed: June 19, 2013
    Publication date: October 31, 2013
    Applicant: PTC Therapeutics Inc.
    Inventors: Gary Mitchell Karp, Seongwoo Hwang, Guangming Chen, Neil Gregory Almstead, Young-Choon Moon
  • Method of maintaining and/or attenuating a decline in quality of life
    Patent number: 8563522
    Abstract: Methods of maintaining and/or attenuating a decline in the quality of life of a mammal comprising the step of administering to the mammal a composition comprising an effective amount of mannoheptulose wherein the effective amount of mannoheptulose provides a dosage to the mammal on a daily basis from about 0.001 gram per kilogram of body weight of the mammal to about 1 gram per kilogram of body weight of the mammal.
    Type: Grant
    Filed: February 13, 2009
    Date of Patent: October 22, 2013
    Assignees: The IAMS Company, GeroScience, Inc.
    Inventors: Josef Pitha, George S Roth, Michael Griffin Hayek, Stefan Patrick Massimino, Michael Anthony Ceddia, Gary Mitchell Davenport, John Russell Burr
  • 1,2,4-oxadiazole benzoic acids
    Patent number: 8486982
    Abstract: Novel 1,2,4-oxadiazole benzoic acid compounds, methods of using and pharmaceutical compositions comprising an 1,2,4-oxadiazole benzoic acid derivative are disclosed. The methods include methods of treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay, or ameliorating one or more symptoms associated therewith.
    Type: Grant
    Filed: June 22, 2012
    Date of Patent: July 16, 2013
    Assignee: PTC Therapeutics, Inc.
    Inventors: Gary Mitchell Karp, Seongwoo Hwang, Guangming Chen, Neil Gregory Almstead, Young-Choon Moon
  • Compositions Comprising a Glucose Anti-Metabolite, BHA, and/or BHT
    Publication number: 20120283197
    Abstract: A composition including a glucose anti-metabolite, BHA, and/or BHT. The composition can be for a companion animal. The composition can be a nutritionally balanced pet food composition.
    Type: Application
    Filed: May 2, 2011
    Publication date: November 8, 2012
    Inventors: Ashok Premchand Luhadiya, Gary Mitchell Davenport, Jin Zhang, George S. Roth, Donald Keith Ingram
  • Compositions Comprising a Glucose Anti-Metabolite and Selenium
    Publication number: 20120282373
    Abstract: A composition including a glucose anti-metabolite and selenium. The composition can be for a companion animal. The composition can include added selenium and endogenous selenium. The composition can be a nutritionally balanced pet food composition.
    Type: Application
    Filed: May 2, 2011
    Publication date: November 8, 2012
    Inventors: Ashok Premchand Luhadiya, Gary Mitchell Davenport, Jin Zhang, George S. Roth, Donald Keith Ingram, Anna Katharine Shoveller, Elizabeth Anne Flickinger
  • 1,2,4-OXADIAZOLE BENZOIC ACIDS
    Publication number: 20120277234
    Abstract: Novel 1,2,4-oxadiazole benzoic acid compounds, methods of using and pharmaceutical compositions comprising an 1,2,4-oxadiazole benzoic acid derivative are disclosed. The methods include methods of treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay, or ameliorating one or more symptoms associated therewith.
    Type: Application
    Filed: June 22, 2012
    Publication date: November 1, 2012
    Inventors: Gary Mitchell Karp, Seongwoo Hwang, Guangming Chen, Neil Gregory Almstead, Young-Choon Moon
  • 1,2,4-oxadiazole benzoic acid compositions and their use in bioassays
    Patent number: 8299105
    Abstract: Novel 1,2,4-oxadiazole benzoic acid compounds, methods of using and pharmaceutical compositions comprising an 1,2,4-oxadiazole benzoic acid derivative are disclosed. The methods include methods of treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay, or ameliorating one or more symptoms associated therewith.
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: October 30, 2012
    Assignee: PTC Therapeutics, Inc.
    Inventors: Gary Mitchell Karp, Seongwoo Hwang, Guangming Chen, Neil Gregory Almstead, Young-Choon Moon